Moderna Inc (MRNA)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	3,229,000	5,076,000	5,052,000	5,155,000	6,826,000	9,097,000	10,486,000	14,708,000	18,810,000	20,675,000	22,284,000	21,933,000	17,736,000	11,016,375	6,199,591	2,013,033	274,490	55,668	56,790	38,378
Total assets	US$ in thousands	14,142,000	15,803,000	15,680,000	16,729,000	18,426,000	19,450,000	21,884,000	24,125,000	25,858,000	26,056,000	26,043,000	27,609,000	24,669,000	20,923,000	16,153,000	12,694,000	7,337,000	4,650,870	3,486,010	2,067,540
Total asset turnover		0.23	0.32	0.32	0.31	0.37	0.47	0.48	0.61	0.73	0.79	0.86	0.79	0.72	0.53	0.38	0.16	0.04	0.01	0.02	0.02

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $3,229,000K ÷ $14,142,000K
= 0.23

Total asset turnover, which measures how efficiently a company is generating revenue from its assets, has shown a fluctuating trend for Moderna Inc over the past few years. From March 31, 2020, and June 30, 2020, the total asset turnover remained low at 0.02, indicating the company was not effectively utilizing its assets to generate revenue during that period.

However, there was a notable improvement in total asset turnover starting from March 31, 2021, where it increased to 0.16, and experienced significant growth through December 31, 2021, reaching 0.72. This upward trend suggests that Moderna Inc was able to generate more revenue relative to its total assets during this period, reflecting improved efficiency in asset utilization.

Subsequently, total asset turnover slightly decreased by the end of December 31, 2022, and continued to decline gradually until December 31, 2024, where it stood at 0.23. Although the ratio has decreased from its peak, Moderna Inc is still generating revenue from its assets, although at a slower pace compared to the earlier periods.

Overall, the total asset turnover for Moderna Inc indicates varying levels of efficiency in utilizing its assets to generate revenue over the analyzed period, with notable improvements followed by some moderation in later periods.